Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Letters|July 10, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancerHongyan Zhang, Longlong Zhang, Yuna He, et al.Theranostics|March 16, 2023
KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8+ T-cell-dependent antitumor immunityQi Wu, Zhou Liu, Zhijie Gao, et al.Oncotarget|May 14, 2015
The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1Chunyan Wang, Zhi Nie, Zhongmei Zhou, et al.The Journal of Clinical Investigation|June 20, 2018
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infectionFubing Li, Yang Li, Huichun Liang, et al.Journal of Advanced Research|August 14, 2024
An essential role of the E3 ubiquitin ligase RNF126 in ensuring meiosis I completion during spermatogenesisWenjing Liu, Xiya Sun, Fubing Li, et al.Journal of Experimental & Clinical Cancer Research : CR|November 29, 2024
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancerYaxun Guo, Yuzhan Li, Zhongmei Zhou, et al.Signal Transduction and Targeted Therapy|July 8, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growthHuichun Liang, Fubing Li, Huan Fang, et al.International Journal of Biological Sciences|March 28, 2022
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast CancerYanjie Kong, Wenlong Ren, Huan Fang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2022
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to RadiotherapyWenjing Liu, Min Zheng, Rou Zhang, et al.Signal Transduction and Targeted Therapy|August 2, 2022
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasisFubing Li, Huichun Liang, Hua You, et al.Pageof 3